MAURA MATHEWS: Open Payments
NPI 1245916949 · WEEHAWKEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 40 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $662 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $483 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $150 |
| GENZYME CORPORATION | 1 | $144 |
| Lilly USA, LLC | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| ABBVIE INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, Wegovy, XIFAXAN, DUPIXENT, Rybelsus, VOQUEZNA, ELYXYB - CELECOXIB, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
